New Report Just Published: World Multiple Myeloma Therapeutics Market Report
...Drugs: An Evaluation of
Pros and Cons II-7
Overtakes Thalomid: Why? II-7
How Effective Wi...rd Line Setting?
Skepticism Overflows II-7
Impedes Stem Cell Harvesting!!: What's the Truth? ...-37
Celgene Obtains Health Canada Approval for revlimid
Cancer Drug II-37
FDA Grants Orphan-D...
BullMarket.com Updates Outlook on Biotech Stocks
...nto a growth story in 2010?
-- Why does Vertex's recent purchase of ViroChemPharma look like a smart move?
-- How does Celgene's principal drug revlimid
have an advantage over other multiple myeloma treatments?
-- What event has been a real black eye for Genzyme?
-- What recent event demonstr...
3-drug combination 'extremely promising' as first-line therapy for multiple myeloma
...known as a proteasome inhibitor that blocks the myeloma cells waste disposal system, creating an accumulation of toxic compounds that poison the cell. revlimid
is a chemical relative of thalidomide that affects several pathways in cancer cells, including immune mechanisms and blood vessel growth to tumors. De...
Pharmion to Present Clinical Data on Key Hematology Products at American Society of Hematology (ASH) Annual Meeting
...in Combination with Etanercept: A Phase II Study (Abstract #1452). -- Poster Board No. 612-I: Preliminary Results from a Phase I Study of revlimid
(Lenalidomide) in Combination with Vidaza (Azacitidine) in Patients with Advanced Myelodysplastic Syndromes (MDS) (Abstract #1458).
Penn's Abramson Cancer Center part of major phase III study for myeloma
... a critical advance toward meeting that need."
(lenalidomide) from Celgene, an oral medication wh...dhere to the wall of tissues where they will grow. revlimid
may also inhibit cancer cells ability to hide from...e the effectiveness and safety of cyclic dosing of revlimid
at 25mg combined with high-does dexamethasone (HDD...
Oral drug sets a new survival standard for bone marrow cancer
...s. Of those patients, 177 were assigned to receive revlimid
(lenalidomide) plus dexamethasone, a steroid hormo...ording to the study results, patients who received revlimid
had a median survival of 29.6 months, compared to 20.2 months for the placebo group. In the revlimid
group, 61 percent of patients responded to therapy...
Drug Combo Boosts Multiple Myeloma Survival
...ients with multiple myeloma.
The combination of revlimid
(lenalidomide) and dexamethasone was given U.S. Fo...rically has been a difficult disease to treat.
is a derivative of thalidomide, with alterations i...were randomized to receive either 25 milligrams of revlimid
or a placebo for the first three weeks. Both group...
New Clinical Trial Results Could Improve Survival for Myeloma Patients
...im findings from a large ongoing clinical trial of revlimid
plus dexamethasone in newly diagnosed patients, su....
"Improved survival with low dose 'dex' and revlimid
is an important finding because it further improve...ry analysis of the ECOG data shows patients taking revlimid
plus low dose dexamethasone had a 96% survival rat...
Revlimid Approved By FDA For Multiple Myeloma
...d Drug Administration has approved the anemia drug revlimid
(lenalidomide) as a treatment for multiple myeloma..., which makes this drug will now be able to market revlimid
for use in multiple myeloma. The treatment regimen...ults of clinical trials in which patients who took revlimid
and dexamethasone survived an average of 29.6 mont...
Lenalidomide, Granted Approval by FDA to Join Multiple Myeloma Drugs
... and Pharmacovigilance said that FDA’s approval of revlimid
(lenalidomide) offered a new oral drug option// to...pplication (sNDA) for an additional indication for revlimid
(lenalidomide), for use in combination with dexame...loma who have received at least one prior therapy. revlimid
is also approved for use in the treatment of patie...